Figure 2From: Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency Changes in PD15 (g/L) in whole lung and in basal, middle and apical regions in patients treated with Prolastin versus placebo (mITT population).Back to article page